n | pD2 | Rmax | |
---|---|---|---|
mg | |||
Control | 9 | 5.10 ± 0.02 | 215 ± 27 |
5-MU protected | 5 | 4.62 ± 0.30 | 123 ± 9 |
BMY7378 protected | 5 | 45 ± 15 |
Preparations were preincubated with selective antagonists (5-MU 0.3 μM or BMY7378 0.5 μM) for 20 min, further incubated with the irreversible α1-adrenoceptor antagonist POB (0.3 μM) for 30 min, and then washed 7 times.
4-150 p < .05, compared with control.